Video

Treat-to-Target in Rheumatoid Arthritis

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond
April 18th 2025

A Pharmacist’s Guide to Blockbuster Patent Expirations: 2025 and Beyond

Sanam Kolia, PharmD, RPh
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
April 17th 2025

Pharmacist Spotlight: Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS

PT Staff Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES, CTTS
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Microscopic View of Blood Cells Related to Aplastic Anemia
April 16th 2025

Allogenic T Regulatory Cell Product CK0801 Granted FDA Orphan Drug Designation for Aplastic Anemia Treatment

Luke Halpern, Assistant Editor
Selective focus close up man hand with dry itchy skin conditions peeling texture detail. Old man hand with flaking and cracked allergic dermatitis on his skin - Image credit: CandyRetriever | stock.adobe.com
April 15th 2025

FDA Grants Interchangeable Designation to Yuflyma for Humira

Kennedy Ferruggia, Assistant Editor